ALPS Medical Breakthroughs ETF (SBIO)

NYSEARCA: SBIO · Real-Time Price · USD
29.90
+0.22 (0.74%)
At close: Mar 27, 2025, 4:00 PM
29.33
-0.57 (-1.91%)
After-hours: Mar 27, 2025, 4:08 PM EST
0.74%
Assets $86.81M
Expense Ratio 0.50%
PE Ratio n/a
Shares Out 2.93M
Dividend (ttm) $1.17
Dividend Yield 3.93%
Ex-Dividend Date Dec 19, 2024
Payout Ratio n/a
1-Year Return -16.01%
Volume 8,471
Open 29.70
Previous Close 29.68
Day's Range 29.70 - 30.01
52-Week Low 29.30
52-Week High 42.73
Beta 0.91
Holdings 105
Inception Date Dec 31, 2014

About SBIO

Fund Home Page

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is issued by SS&C.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol SBIO
ETF Provider SS&C
Index Tracked S-Network Medical Breakthroughs Index

Top 10 Holdings

34.99% of assets
Name Symbol Weight
Axsome Therapeutics, Inc. AXSM 4.58%
Verona Pharma plc VRNA 4.51%
Alkermes plc ALKS 4.51%
PTC Therapeutics, Inc. PTCT 3.67%
Avidity Biosciences, Inc. RNA 3.31%
Zai Lab Limited ZLAB 3.21%
Akero Therapeutics, Inc. AKRO 2.95%
Rhythm Pharmaceuticals, Inc. RYTM 2.87%
Crinetics Pharmaceuticals, Inc. CRNX 2.73%
Merus N.V. MRUS 2.66%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 19, 2024 $1.174 Dec 26, 2024
Dec 21, 2023 $0.07106 Dec 27, 2023
Dec 19, 2019 $0.01585 Dec 27, 2019
Dec 20, 2018 $0.78406 Dec 27, 2018
Dec 21, 2017 $0.57949 Dec 28, 2017
Full Dividend History

News

This Tech Sector ETF Could Zig Where Others Zag

With tech earnings arriving, many investors are still likely fearing a downturn for key information technology stocks. The so-called Magnificent Seven stocks delivered significant performance for inve...

4 weeks ago - ETF Trends

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...

4 weeks ago - Seeking Alpha

SBIO ETF: Betting On Medical Breakthroughs

ALPS Medical Breakthroughs ETF is rated Hold due to high fees, low yield, and mixed performance compared to other healthcare ETFs. The SBIO ETF focuses on small and mid-cap biotech companies with drug...

3 months ago - Seeking Alpha

Advacam & Vector Space Biosciences sign Letter of Intent (LOI) to Develop AI Models & CubeSat Payloads for the Space Industry

LA JOLLA, Calif.--(BUSINESS WIRE)---- $SBIO #Advacam--Advacam, provider of radiation detectors that map radiation aboard the International Space Station (ISS) and Vector Space Biosciences (crypto symb...

6 months ago - Business Wire

Vector Space Biosciences (SBIO) Is Now Available for Trading on LBank Exchange

Road Town, Virgin Islands--(Newsfile Corp. - September 24, 2023) - LBank Exchange, a global digital asset trading platform, listed Vector Space Biosciences (SBIO) on September 15, 2023. For all users ...

1 year ago - Newsfile Corp

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

2 years ago - Seeking Alpha